The Gaithersburg biotechnology company, Novavax, announced Monday morning data from phase 3 of its COVID-19 vaccine trials which were conducted in the United States and Mexico. Novavax found that the trial, which began in December and enrolled 29,960 participants, had an overall efficacy rate of 90.04%. Last year, Novavax was awarded $1.6 billion from the […]
John Trizzino
June 11, 2021 |
Novavax Expected to Make Announcement About Data from Vaccine Trials Soon
Novavax CEO Stan Erck said that the company will likely make an announcement about data from phase 3 of its COVID-19 vaccine trials as soon as next week. “I’m happy to say that the data are coming very soon, in fact, we hope to announce those data next week,” Erck said. The comments were made […]
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia